Alzamend Neuro

ALZN

Market cap $6.56M

ALZN Hedge Fund Activity: Q1 2026 in Review

12 of the 8,150 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q1 2026, worth a combined $122K — down 73% from $447K a quarter earlier.

Fund positioning in ALZN was balanced in Q1 2026: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $36.3K. The largest seller was DRW Securities, exiting entirely with an estimated $212K sold.

• 12 institutional investors held Alzamend Neuro (ALZN) as of Q1 2026, down from 13 in Q4 2025.
• Funds reported $122K of Alzamend Neuro stock for Q1 2026, down 73% quarter-over-quarter.
• 4 funds opened new Alzamend Neuro positions in Q1 2026 and 4 closed out, a net change of 0 holders.
• The largest Alzamend Neuro buyer in Q1 2026 was Geode Capital Management, an estimated $36.3K added.
• The largest Alzamend Neuro seller in Q1 2026 was DRW Securities, an estimated $212K sold.

Based on aggregated 13F filings for Q1 2026.